Company Monitoring Page for Genentech

latest headlines for company on cafepharma

Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design
Xtalks
Mon, 12/10/18 - 07:07 pm
Tags:
clinical trials, Multiple Myeloma, adaptive trial design, AbbVie, Celgene, Eli Lilly, Genentech, Janssen, Takeda
Genentech Scores FDA Approval for Tecentriq and Avastin Combo in NSCLC
BioSpace
Fri, 12/7/18 - 11:59 am
Tags:
Genentech, FDA, Tecentriq, Avastin, non-squamous cell non-small cell lung cancer
Tecentriq could be first front-line SCLC therapy approved in two decades
BioCentury
Wed, 12/5/18 - 07:46 pm
Tags:
FDA, Tecentriq, Genentech, extensive-stage small cell lung cancer
Roche Gains Place in NASH Race with Purchase of Jecure Therapeutics
Xconomy
Tue, 11/27/18 - 11:41 pm
Tags:
Roche, Jecure Therapeutics, M&A, NASH, Genentech
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
Yahoo/Guru Focus
Sat, 11/24/18 - 01:27 pm
Tags:
Roche, Genentech, Venclexta, FDA, AML, acute myeloid leukemia
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
Tags:
cancer, breast cancer, lung cancer, drug approvals, AstraZeneca, Takeda, Ariad Pharmaceuticals, Merck, Pfizer, Novartis, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Puma Biotechnology, Mylan, Genentech
Genentech to pay Immunocore $100M to co-develop preclinical MAGE-A4 drug
Fierce Biotech
Mon, 11/19/18 - 09:54 am
Tags:
Genentech, Roche, MAGE-A4, IMC-C103C, Immunocore
Roche’s Tecentriq gets fast review in triple negative breast cancer
Pharmaforum
Tue, 11/13/18 - 09:51 am
Tags:
Roche, Genentech, Tecentriq, Celgene, Abraxane, FDA, triple negative breast cancer
Genentech details claims Sanofi partner JHL used stolen trade secrets to develop rival drugs at an 'astonishing pace'
Endpoints
Fri, 11/9/18 - 12:10 pm
Tags:
Genentech, Roche, JHL Biotech, trade secrets
Roche and AbbVie Push Towards First-Line CLL Treatment
BioSpace
Thu, 11/1/18 - 11:28 am
Tags:
Roche, Genentech, AbbVie, clinical trials, Venclexta, Gazyva, CLL, chronic lymphocytic leukemia
Genentech staff ‘funneled secrets to Taiwan biosimilar firm,’ prosecutors say
Fierce Biotech
Tue, 10/30/18 - 06:59 pm
Tags:
Genentech, trade secrets, Taiwan, biosimilars
Roche expands its PhIII program for Eylea rival as long-acting data back its blockbuster contender faricimab
Endpoints
Mon, 10/29/18 - 10:27 am
Tags:
Roche, Genentech, Regeneron, Novartis, Eylea, faricimab, wet-AMD
Sanofi, Genentech Both Eye U.S. Expansions; Could Add up to 2,300 Jobs
BioSpace
Wed, 10/17/18 - 09:17 am
Tags:
Sanofi, Cambridge MA, Genentech, Oregon
Roche and Novartis Strengthen Their Presence in the MS Market
BioSpace
Thu, 10/11/18 - 09:35 am
Tags:
Genentech, Roche, Ocrevus, Novartis, siponimod, FDA, MS, multiple sclerosis
Two Genentech vets reunite at Immune-Onc to help steer its $33M drive to the clinic
Endpoints
Sat, 09/22/18 - 05:19 pm
Tags:
Immune-Onc, Genentech
Genentech and Hemophilia Patients Eye Oct. 4 for Hemlibra Ruling
BioSpace
Tue, 09/18/18 - 10:14 pm
Tags:
FDA, Genentech, Hemlibra, hemophilia
Roche's Child Arthritis Drug's New Formulation Gets FDA Nod
Yahoo/Zacks.com
Sat, 09/15/18 - 02:19 pm
Tags:
Roche, Genentech, FDA, Actemra, systematic juvenile idiopathic arthritis
Roche CEO Severin Schwan is keeping his hand on the budget ax
Endpoints
Fri, 09/14/18 - 11:51 am
Tags:
Roche, Genentech, Severin Schwan, R&D, layoffs, reorganization
New Flu Season, New Flu Drug from Genentech
BioSpace
Thu, 09/13/18 - 09:59 am
Tags:
Genentech, balox
In a rare delay for the fast PD-1/L1 crowd, FDA tells Roche to wait on its Tecentriq/Avastin triple for lung cancer
Endpoints
Thu, 09/6/18 - 11:42 am
Tags:
Genentech, Roch, Tecentriq, Avastin, lung cancer, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.